Calendar NeoPharm CO., LTD.

Equities

A092730

KR7092730001

End-of-day quote Korea S.E. 23:00:00 04/07/2024 BST 5-day change 1st Jan Change
27,900 KRW -2.28% Intraday chart for NeoPharm CO., LTD. -3.12% +7.93%

Chart calendar NeoPharm CO., LTD.

4919440bdbfe04ed18d3c16bb05.OsoEc_VG2qJ-altqbHgVegntXlA3PVTOZr2Vkx7FElE.Dq5CSrAovPYPECEbGElBL2GbbypUWAWGUdPH2maRJDJ8mmEdjyK_0DEnYw~8a1064bc402029774e06737979a125a8

Upcoming events on NeoPharm CO., LTD.

08/08/2024 Q2 2024 Earnings Release (Projected)
13/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on NeoPharm CO., LTD.

02/05/2024 Q1 2024 Earnings Release
01/02/2024 Q4 2023 Earnings Release
02/11/2023 Q3 2023 Earnings Release
03/08/2023 Q2 2023 Earnings Release
11/05/2023 Q1 2023 Earnings Release
22/03/2023 Annual General Meeting
14/03/2023 Q4 2022 Earnings Release
10/11/2022 Q3 2022 Earnings Release
11/08/2022 Interim 2022 Earnings Release
12/05/2022 Q1 2022 Earnings Release
07/02/2022 FY 2021 Earnings Release
12/08/2021 Interim 2021 Earnings Release
13/05/2021 Q1 2021 Earnings Release
16/03/2021 FY 2020 Earnings Release

Past dividends on NeoPharm CO., LTD.

26/12/2023 Annual 750 KRW
27/12/2022 Annual 700 KRW
28/12/2021 Annual 700 KRW
28/12/2020 Annual 650 KRW
26/12/2019 Annual 750 KRW
26/12/2018 Annual 650 KRW
26/12/2017 Annual 500 KRW
27/12/2016 Annual 350 KRW
28/12/2015 Annual 250 KRW
28/12/2014 Annual 250 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW
Released
Forecast
Spread
83,2
84,8
-1.82%
81,6
81,5
0.18%
87,9
88,7
-0.83%
0,00


97,1
96,6
0.52%

120

EBITDA
Billions KRW
Released
Forecast
Spread
24,2
25,9
-6.54%
23,4
21,9
6.98%
23,9
24,3
-1.38%
0,00


26,9
26,7
0.85%

29,0

EBIT
Billions KRW
Released
Forecast
Spread
23,0
24,6
-6.67%
21,9
20,2
8.56%
22,4
23,2
-3.18%
0,00


25,3
25,3
0.03%

27,5

Earnings before Tax (EBT)
Billions KRW
Released
Forecast
Spread
23,5
25,6
-8.04%
22,9
21,7
5.86%
23,8
24,1
-1.1%
0,00


29,4
29,5
-0.43%

29,1

Net income
Billions KRW
Released
Forecast
Spread
19,2
19,4
-0.8%
18,1
17,0
6.61%
17,7
18,1
-1.96%
17,0


23,2
23,1
0.49%

23,0

EPS
KRW
Released
Forecast
Spread
2 345
2 397
-2.17%
2 296
2 073
10.76%
2 265
2 203
2.81%
2 177


2 968
2 820
5.25%

2 797

Announcement Date07/02/2008/02/2108/02/2215/03/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW
Released
Forecast
Spread
22,3
23,5
-4.76%
21,5
22,9
-6.34%
27,2
26,7
1.92%
28,2
28,0
0.77%

30,5


28,0


33,4

EBIT
Billions KRW
Released
Forecast
Spread
6,34
6,74
-5.92%
4,95
6,12
-19.16%
6,93
6,90
0.48%
6,79
6,50
4.48%

7,30


5,70


7,90

Earnings before Tax (EBT)
Billions KRW
Released
Forecast
Spread
6,82
7,01
-2.61%
5,67
6,39
-11.33%















Net income
Billions KRW
Released
Forecast
Spread
4,92
5,40
-8.73%
4,60
4,92
-6.56%















Announcement Date06/05/2205/08/2202/02/2403/05/24---

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. Calendar NeoPharm CO., LTD.